BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38870290)

  • 1. Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interaction.
    Liu Y; Jiang JJ; Du SY; Mu LS; Fan JJ; Hu JC; Ye Y; Ding M; Zhou WY; Yu QH; Xia YF; Xu HY; Shi YJ; Qian SW; Tang Y; Li W; Dang YJ; Dong X; Li XY; Xu CJ; Tang QQ
    Science; 2024 Jun; 384(6701):eadk5382. PubMed ID: 38870290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal expression of uncoupling protein-2 correlates with CYP11A1 expression in polycystic ovary syndrome.
    Liu Y; Jiang H; He LY; Huang WJ; He XY; Xing FQ
    Reprod Fertil Dev; 2011; 23(4):520-6. PubMed ID: 21557918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.
    Bakhshalizadeh S; Amidi F; Alleyassin A; Soleimani M; Shirazi R; Shabani Nashtaei M
    Syst Biol Reprod Med; 2017 Jun; 63(3):150-161. PubMed ID: 28345956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype.
    McAllister JM; Modi B; Miller BA; Biegler J; Bruggeman R; Legro RS; Strauss JF
    Proc Natl Acad Sci U S A; 2014 Apr; 111(15):E1519-27. PubMed ID: 24706793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol side-chain cleavage gene expression in theca cells: augmented transcriptional regulation and mRNA stability in polycystic ovary syndrome.
    Wickenheisser JK; Biegler JM; Nelson-Degrave VL; Legro RS; Strauss JF; McAllister JM
    PLoS One; 2012; 7(11):e48963. PubMed ID: 23155436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovary syndrome: possible involvement of androgen-induced, chemerin-mediated ovarian recruitment of monocytes/macrophages.
    Lima PDA; Nivet AL; Wang Q; Chen YA; Leader A; Cheung A; Tzeng CR; Tsang BK
    Biol Reprod; 2018 Oct; 99(4):838-852. PubMed ID: 29688269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-androgenic effect of quercetin on hyperandrogenism and ovarian dysfunction induced in a dehydroepiandrosterone rat model of polycystic ovary syndrome.
    Mahmoud AA; Elfiky AM; Abo-Zeid FS
    Steroids; 2022 Jan; 177():108936. PubMed ID: 34752810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
    Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
    Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome.
    Romero-Ruiz A; Skorupskaite K; Gaytan F; Torres E; Perdices-Lopez C; Mannaerts BM; Qi S; Leon S; Manfredi-Lozano M; Lopez-Rodriguez C; Avendaño MS; Sanchez-Garrido MA; Vazquez MJ; Pinilla L; van Duin M; Kohout TA; Anderson RA; Tena-Sempere M
    Hum Reprod; 2019 Dec; 34(12):2495-2512. PubMed ID: 31820802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Analysis of CYP11A1 Variants with Polycystic Ovary Syndrome: a Case-Control Study from North India.
    Kaur R; Kaur T; Sudhir N; Kaur A
    Reprod Sci; 2021 Oct; 28(10):2951-2960. PubMed ID: 34231171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome.
    Arroyo P; Ho BS; Sau L; Kelley ST; Thackray VG
    PLoS One; 2019; 14(9):e0223274. PubMed ID: 31568518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel promising reproductive and metabolic effects of Cicer arietinum L. extract on letrozole induced polycystic ovary syndrome in rat model.
    Ali SE; El Badawy SA; Elmosalamy SH; Emam SR; Azouz AA; Galal MK; Abd-Elsalam RM; Issa MY; Hassan BB
    J Ethnopharmacol; 2021 Oct; 278():114318. PubMed ID: 34111539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
    Sanchez-Garrido MA; Tena-Sempere M
    Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BMP4-Smad signaling pathway regulates hyperandrogenism development in a female mouse model.
    Liu Y; Du SY; Ding M; Dou X; Zhang FF; Wu ZY; Qian SW; Zhang W; Tang QQ; Xu CJ
    J Biol Chem; 2017 Jul; 292(28):11740-11750. PubMed ID: 28572510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome.
    Pusalkar M; Meherji P; Gokral J; Chinnaraj S; Maitra A
    Fertil Steril; 2009 Aug; 92(2):653-9. PubMed ID: 18725155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [(TTTTA), polymorphism in the promoter of the CYP11A1 gene in the pathogenesis of polycystic ovary syndrome].
    Prazáková S; Vanková M; Bradnová O; Lukásová P; Vcelák J; Dvoráková K; Vondra K; Vrbíková J; Bendlová B
    Cas Lek Cesk; 2010; 149(11):520-5. PubMed ID: 21391350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apelin receptor modulation mitigates letrozole-induced polycystic ovarian pathogenesis in mice.
    Anima B; Gurusubramanian G; Roy VK
    Cytokine; 2024 Jul; 179():156639. PubMed ID: 38733946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of Lon protease 1 lysine crotonylation aggravates mitochondrial dysfunction in polycystic ovary syndrome.
    Xie Y; Chen S; Guo Z; Tian Y; Hong X; Feng P; Xie Q; Yu Q
    MedComm (2020); 2023 Oct; 4(5):e396. PubMed ID: 37817894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test.
    Rosenfield RL; Mortensen M; Wroblewski K; Littlejohn E; Ehrmann DA
    Hum Reprod; 2011 Nov; 26(11):3138-46. PubMed ID: 21908468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.